Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design

Muscle and Nerve

Volumn 33, Issue 1, 2006, Pages 127-132

  Schmidt, Eric P ^a   Drachman, Daniel B ^b   Wiener, Charles M ^a   Clawson, Lora ^b   Kimball, Richard ^b   Lechtzin, Noah ^a  

^a Department of Medicine ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Prognosis; Pulmonary function; Spirometry; Therapeutic trial design

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; EVALUATION; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; METHODOLOGY; PATIENT COUNSELING; PREDICTION; PREDICTOR VARIABLE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RESPIRATORY FAILURE; SNIFFING; SPIROMETRY; STANDING; SUPINE POSITION; SURVIVAL TIME; THERAPEUTIC TRIAL DESIGN; TRACHEOTOMY; TRANSDIAPHRAGMATIC SNIFF PRESSURE;

AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; CARBON DIOXIDE; CLINICAL TRIALS; COHORT STUDIES; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PARTIAL PRESSURE; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES;

EID: 30344479450     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20450     Document Type: Article

References (19)

1. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
2. Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory aids. Chest 2002;12:92-98.
3. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(Suppl):96-107.
4. Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002;59:99-103.
5. del Aguila MA, Longstreth WT, Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813-819.
6. Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol 1999;46:887-893.
7. Goldman H, Becklake M. Respiratory function tests: normal rallies at median altitudes and the prediction of normal results. Am Rev Tuberc 1959;79:457-467.
8. Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 2001;191:75-78.
9. Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest 2002;121:436-442.
10. Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ. Amyotrophic lateral sclerosis: mortality risk during the course of disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci 1997;152 (Suppl 1):S10-17.
11. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001;124:2000-2013.
12. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25:709-714.
13. Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005;171:269-274.
14. Mustfa N, Moxham J. Respiratory muscle assessment in motor neurone disease. QJM 2001;94:497-502.
15. Polkey MI, Lyall RA, Green M, Leigh NP, Moxham J. Expiratory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998;158:734-741.
16. Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43:1316-1322.
17. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700.
18. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998;50:66-72.
19. Szeinberg A, Tabachnik E, Rashed N, McLaughlin FJ, England S, Bryan CA, et al. Cough capacity in patients with muscular dystrophy. Chest 1988;94:1232-1335.